의약 사료첨가제 시장 : 첨가제 유형, 형태, 원료, 기능, 동물 유형별 - 세계 예측(2026-2032년)

The Medicinal Feed Additives Market is projected to grow by USD 23.43 billion at a CAGR of 5.40% by 2032.

Executive Introduction to Medicinal Feed Additives

Medicinal feed additives remain a critical part of modern animal health management, supporting disease prevention, therapeutic intervention, and productivity in poultry, swine, cattle, aquaculture, and companion livestock systems. The category includes veterinary-authorized antimicrobials, anticoccidials, antiparasitics, medicated premixes, and other regulated feed-delivered therapeutics used under national veterinary medicine and feed safety frameworks.

Demand is shaped by intensive protein production, recurring enteric and respiratory disease pressure, and the need to protect feed conversion, mortality rates, and animal welfare. At the same time, antimicrobial resistance policies, veterinary feed directive requirements, maximum residue limit enforcement, withdrawal-period compliance, and retailer antibiotic-use standards are redefining how manufacturers, feed mills, veterinarians, and producers deploy medicinal feed additives across global supply chains.

Transformative Shifts in the Medicinal Feed Additives Landscape

The medicinal feed additives landscape is shifting from broad preventive medication toward diagnosis-led, veterinary-supervised, and species-specific use. In the United States, the FDA's Veterinary Feed Directive framework tightened oversight of medically important antimicrobials in feed, while the European Union has prohibited antibiotic growth promoters since 2006 and strengthened controls through veterinary medicinal product and medicated feed regulations.

These changes are accelerating investment in compliant medicated premix manufacturing, traceable dosing systems, residue risk management, and alternatives that reduce disease incidence before medication is required. Growth is increasingly tied to integrated animal health programs combining biosecurity, vaccination, nutrition, microbiome support, diagnostics, and targeted therapeutics rather than standalone additive sales.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler for precision medication in animal production. Feed mills and integrators are using connected farm records, diagnostic data, mortality trends, feed intake signals, environmental conditions, and treatment histories to identify disease risk earlier and optimize when medicated feed is justified under veterinary oversight.

AI also improves quality assurance across medicated premix and compound feed production by supporting formulation checks, carryover risk detection, inventory planning, batch anomaly monitoring, and digital documentation in dosing systems. As regulators and buyers demand auditable evidence, AI-enabled traceability can strengthen compliance with withdrawal periods, prescription controls, residue prevention, and antimicrobial stewardship commitments.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

Asia-Pacific is a major demand center because China, India, Japan, South Korea, Australia, and ASEAN markets combine large animal protein consumption with diverse poultry, swine, dairy, ruminant, and aquaculture production systems. Regulatory maturity varies, but the region is moving toward stronger veterinary drug oversight, residue testing, antimicrobial-use controls, and disease surveillance, particularly where food safety, export access, and intensive production systems are priorities.

North America is defined by high regulatory scrutiny, advanced feed manufacturing, veterinary supervision, and formal controls over medically important antimicrobials in feed. Latin America, led by Brazil and Mexico, continues to emphasize poultry, beef, pork, and aquaculture competitiveness, making residue compliance, animal health documentation, and export-market acceptability central to medicinal feed additive adoption. Europe maintains one of the most restrictive antimicrobial-use environments through long-standing bans on antibiotic growth promotion, strengthened veterinary medicine rules, and comprehensive monitoring programs. The Middle East prioritizes food security, regulated imports, poultry expansion, and biosecurity-led disease management, while Africa's opportunities are linked to livestock disease control, veterinary access, feed modernization, and the need for safe, quality-assured animal protein production.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

ASEAN demand is supported by poultry, swine, and aquaculture expansion, but market entry requires close attention to country-level product registration, veterinary prescription practices, feed mill capability, residue rules, and disease-specific protocols. GCC countries rely heavily on food security strategies, biosecurity upgrades, regulated imports of veterinary products, and controlled livestock and poultry production, creating opportunities for suppliers that can demonstrate safety, documentation, cold-chain or handling integrity where required, and halal-aligned supply chain practices where relevant.

The European Union sets a global benchmark for antimicrobial stewardship, medicated feed controls, pharmacovigilance, and residue monitoring, influencing multinational buyers and food-chain standards beyond Europe. BRICS countries represent large-scale animal production, rising protein consumption, and fast-changing veterinary policy environments, with China, India, Brazil, Russia, and South Africa each balancing productivity, disease control, and food safety oversight. G7 markets emphasize surveillance, traceability, responsible use, and high documentation standards across animal health supply chains. NATO membership does not determine feed policy, but many NATO countries overlap with high-compliance North American and European markets where regulatory alignment, supply security, resilient feed systems, and veterinary medicine availability are strategic priorities.

Key Country Insights Across Major Livestock Markets

The United States is anchored by FDA oversight, Veterinary Feed Directive compliance, and large integrated poultry, swine, dairy, and cattle systems that require auditable medicated feed practices. Canada aligns strong veterinary controls with residue monitoring and food safety assurance, while Mexico balances domestic livestock growth with North American trade requirements and disease-management needs. Brazil is a global animal protein exporter, making compliant medication, disease control, traceability, and market-access documentation essential for poultry, beef, and pork value chains.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate under strict antimicrobial stewardship expectations, with strong emphasis on veterinary oversight, residue compliance, and responsible therapeutic use in poultry, swine, dairy, and ruminant systems. Russia maintains significant poultry and swine production with localized regulatory requirements and a focus on domestic supply resilience. China and India provide scale and disease-management demand across intensive and fragmented production systems, while Japan and South Korea prioritize food safety, veterinary compliance, and high-quality production standards. Australia combines export-oriented livestock systems with strict biosecurity, residue controls, and animal health governance, supporting targeted and well-documented medicinal feed additive use.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize veterinary-supervised product portfolios, validated dosing accuracy, species-specific therapeutic positioning, and regulatory documentation that supports audits, export certification, and buyer assurance programs. Commercial teams should segment demand by species, disease burden, regulation, residue sensitivity, antimicrobial stewardship requirements, and feed mill capability rather than treating medicinal feed additives as a uniform market.

Manufacturers should invest in residue risk controls, medicated feed cleanout protocols, pharmacovigilance, stability testing, quality management, and digital traceability. Partnerships with veterinarians, diagnostics providers, nutrition specialists, feed manufacturers, and integrated producers can create differentiated health programs that reduce unnecessary antimicrobial exposure while preserving access to effective therapeutics when clinically justified.

Research Methodology

This executive summary is built on a structured secondary-research approach using publicly available regulatory, scientific, and industry sources. Core references include frameworks and guidance from the U.S. FDA, European Commission, European Medicines Agency, Codex Alimentarius, World Organisation for Animal Health, World Health Organization, Food and Agriculture Organization, and national veterinary authorities.

The analysis triangulates policy direction, animal production dynamics, disease-management needs, feed manufacturing practices, antimicrobial stewardship requirements, residue controls, and trade requirements. Insights are presented qualitatively to avoid unsupported market-size claims and to focus on verifiable drivers, constraints, and strategic implications for medicinal feed additive stakeholders.

Conclusion

Medicinal feed additives are evolving from volume-driven medication tools into tightly governed components of integrated animal health systems. The strongest opportunities are emerging where organizations can combine regulatory compliance, veterinary credibility, precise feed delivery, residue control, and measurable disease-control outcomes.

Future competitiveness will depend on stewardship, traceability, quality assurance, and innovation as much as product efficacy. Stakeholders that align therapeutic use with diagnostics, biosecurity, vaccination, nutrition, and digital quality systems will be best positioned to serve producers, regulators, and food-chain customers in a more accountable global animal health market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medicinal Feed Additives Market, by Additive Type

• 7.1. Acidifiers
  • 7.1.1. Inorganic Acidifiers
  • 7.1.2. Organic Acidifiers
• 7.2. Antibiotics
  • 7.2.1. Aminoglycosides
  • 7.2.2. Beta-Lactams
  • 7.2.3. Tetracyclines
• 7.3. Coccidiostats
  • 7.3.1. Ionophores
  • 7.3.2. Synthetic Coccidiostats
• 7.4. Enzymes
  • 7.4.1. Phytase
  • 7.4.2. Protease
  • 7.4.3. Xylanase
• 7.5. Mycotoxin Detoxifiers
  • 7.5.1. Binders
  • 7.5.2. Biotransformation Agents
• 7.6. Phytogenics
  • 7.6.1. Essential Oils
  • 7.6.2. Herbal Extracts
• 7.7. Prebiotics
  • 7.7.1. Fructooligosaccharides
  • 7.7.2. Mannan Oligosaccharides
• 7.8. Probiotics
  • 7.8.1. Bacillus
  • 7.8.2. Bifidobacterium
  • 7.8.3. Lactobacillus

8. Medicinal Feed Additives Market, by Form

• 8.1. Liquid
• 8.2. Pellet
• 8.3. Powder

9. Medicinal Feed Additives Market, by Source

• 9.1. Biological
  • 9.1.1. Fermentation Derived
  • 9.1.2. Microbial Derived
• 9.2. Mineral
• 9.3. Plant Extract
  • 9.3.1. Essential Oils
  • 9.3.2. Herbal Extracts
• 9.4. Synthetic

10. Medicinal Feed Additives Market, by Function

• 10.1. Disease Prevention And Control
  • 10.1.1. Antimicrobial Therapy
  • 10.1.2. Coccidiosis Control
• 10.2. Growth Promotion
  • 10.2.1. Feed Efficiency
  • 10.2.2. Weight Gain
• 10.3. Gut Health Improvement
  • 10.3.1. Digestive Enzyme Support
  • 10.3.2. Microbiota Balance

11. Medicinal Feed Additives Market, by Animal Type

• 11.1. Aquatic Animals
  • 11.1.1. Fish
  • 11.1.2. Shrimp
• 11.2. Companion Animals
  • 11.2.1. Cats
  • 11.2.2. Dogs
• 11.3. Poultry
  • 11.3.1. Broilers
  • 11.3.2. Layers
• 11.4. Ruminants
  • 11.4.1. Beef Cattle
  • 11.4.2. Dairy Cattle
  • 11.4.3. Sheep And Goats
• 11.5. Swine
  • 11.5.1. Growers
  • 11.5.2. Sows
  • 11.5.3. Weaners

12. Medicinal Feed Additives Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Medicinal Feed Additives Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Medicinal Feed Additives Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Adisseo France S.A.S.
• 16.2. Alltech, Inc.
• 16.3. Archer-Daniels-Midland Company
• 16.4. Azelis Group
• 16.5. BASF SE
• 16.6. Bentoli, Inc.
• 16.7. Biostadt India Ltd.
• 16.8. Boehringer Ingelheim International GmbH
• 16.9. Cargill, Inc.
• 16.10. CHS Inc.
• 16.11. Clariant International Ltd.
• 16.12. Elanco Animal Health Incorporated
• 16.13. Evonik Industries AG
• 16.14. EW Nutrition GmbH
• 16.15. Kemin Industries, Inc.
• 16.16. Merck & Co., Inc.
• 16.17. Nicosia International
• 16.18. Novozymes A/S
• 16.19. Novus International, Inc.
• 16.20. Nutreco N.V.
• 16.21. Oil-Dri Corporation of America
• 16.22. Orffa
• 16.23. Palital Feed Additives B.V. by Arvesta BV
• 16.24. Phibro Animal Health Corporation
• 16.25. Promois International
• 16.26. Purina Animal Nutrition LLC by Land O'Lakes, Inc.
• 16.27. Zagro Singapore Pte Ltd.
• 16.28. Zoetis Inc.